From the Journals

Link between bipolar disorder and CVD mortality explained?


 

FROM THE JOURNAL OF CLINICAL PSYCHIATRY

Observable changes in youth

In a comment, Jess G Fiedorowicz, MD, PhD, head and chief, department of mental health, Ottawa Hospital Research Institute, noted that individuals with BD “have a much higher risk of CVD, which tends to develop earlier and shortens life expectancy by more than a decade.”

This cardiovascular risk “appears to be acquired over the long-term course of illness and proportionate to the persistence and severity of mood symptoms, which implies that mood syndromes, such as depression and mania, themselves may induce changes in the body relevant to CVD,” said Dr. Fiedorowicz, who is also a professor in the department of psychiatry and senior research chair in adult psychiatry at the Brain and Mind Research Institute, University of Ottawa, and was not involved with the study.

The study “adds to a growing body of evidence that mood syndromes may enact physiological changes that may be relevant to risk of CVD. One important aspect of this study is that this can even be observed in young sample,” he said.

This study was funded by the Canadian Institutes of Health Research and a Miner’s Lamp Innovation Fund from the University of Toronto. Dr. Goldstein and coauthors declare no relevant financial relationships. Dr. Fiedorowicz receives an honorarium from Elsevier for his work as editor-in-chief of the Journal of Psychosomatic Research.

A version of this article first appeared on Medscape.com.

Pages

Recommended Reading

First trimester lithium exposure ups risk of cardiac malformations
MDedge Cardiology
Bipolar patients’ relatives face increased cardiovascular risk
MDedge Cardiology
Siblings of bipolar disorder patients at higher cardiometabolic disease risk
MDedge Cardiology
COVID-19 exacerbating challenges for Latino patients
MDedge Cardiology
Repurposing cardiovascular drugs for serious mental illness
MDedge Cardiology
Blood pressure meds tied to increased schizophrenia risk
MDedge Cardiology
‘Remarkable’ response to diabetes drug in resistant bipolar depression
MDedge Cardiology
Obesity treatment in mental illness: Is semaglutide a game changer?
MDedge Cardiology
Antipsychotic tied to dose-related weight gain, higher cholesterol
MDedge Cardiology